search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Train hard is smart for the heart.


- candidate number13462
- NTR NumberNTR3671
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR22-okt-2012
- Secondary IDs2010/065 / NL31612.091.10; METC / ABR
- Public TitleTrain hard is smart for the heart.
- Scientific TitleTrain hard is smart for the heart: An exercise study on clinical outcome and mechanisms in heart failure patients.
- ACRONYMTrain hard is smart for the heart
- hypothesisWe expect that the control group will show no increase or possibly even a decrease in physical fitness in the three-month period of the study. We expect that continuous training will produce a moderate increase in physical fitness however, we expect that interval training will induce the largest improvement in physical fitness in heart failure patients.
- Healt Condition(s) or Problem(s) studiedHeart failure, Congestive heart failure, Decompensatio Cordis
- Inclusion criteria1. Heart failure NYHA classification II/III;
2. Ejection fraction < 45%;
3. Stable situation (clinically and pharmacological).
- Exclusion criteria1. Diabetes mellitus;
2. Hypercholesterolaemia;
3. Exercise-induced ischaemia;
4. Pre-menopausal females;
5. Pathology/disease that restricts patients from participation to exercise.
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 12-jul-2011
- planned closingdate31-mei-2015
- Target number of participants84
- Interventions1. 12 weeks of high-intensity interval exercise training, twice a week;
2. 12 weeks of moderate-intensity continuous exercise training, twice a week;
3. A control group who recieves usual care.
- Primary outcome1. Physcial fitness;
2. Brachial artery NO-dependent endothelium-dependent vasodilation;
3. Forearm resistance artery vascular bed NO-(in)dependent vasodilation;
4. Contribution of ET to the baseline forearm resistance artery vascular tone.
- Secondary outcome1. Cardiac structure and function;
2. Blood parameters that are (in)directly related to the progression and prognosis of HF;
3. Contribution of ET or NO to the exercise-induced vasodilation of the forearm vascular bed.
- TimepointsZero weeks (baseline) and twelve weeks (post-intervention).
- Trial web siteN/A
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESDrs. Nathalie M.M. Benda
- CONTACT for SCIENTIFIC QUERIESDr. Dick H.J. Thijssen
- Sponsor/Initiator Radboud University Medical Center Nijmegen
- Funding
(Source(s) of Monetary or Material Support)
Radboud University Medical Centre Nijmegen
- PublicationsN/A
- Brief summaryRationale:
In Western countries, heart failure (HF) is a major cause of death. Despite current advances in the pharmacological management of HF, the prevalence is rapidly increasing and the prognosis remains poor. Physical fitness is the single best predictor of both cardiac and all-cause deaths among patients with cardiovascular disease and outperforms ejection fraction as a prognostic index (for survival) in HF. Despite the overwhelming evidence to promote physical activity, little is known regarding the type of exercise that yields optimal beneficial effects in HF. Some studies in healthy subjects or those with cardiovascular risk suggest greater fitness and cardiovascular adaptations after high intensity exercise than with 'traditional' moderate exercise. The rationale is that high intensity exercise (i.e. short bouts of exercise at ~90% of the maximal heart rate) allows patients to complete work at higher workload/intensity, but for a short period of time, inducing beneficial peripheral adaptations in vessels and muscles, without overloading the heart. A sound comparison between the effects of 'traditional' moderate versus high intensity exercise training in HF patients has never been examined. Moreover, little is known about the underlying mechanisms that explain the beneficial effects of exercise in HF.

Objective:
This study aims to investigate the effects of 12 weeks of continuous versus interval exercise training versus a HF control group on physical fitness and cardiovascular health in heart failure patients. Furthermore the mechanisms of exercise-induced improvements in cardiovascular health will be investigated through vascular function measurements and assessments of changes on an genetic level.

Hypothesis:
We expect that continuous training will produce a moderate increase in physical fitness and accordingly a modest improvement in prognosis for heart failure patients. We expect that interval training will provide an optimal stimulus for peripheral improvements, leading to beneficial adaptations in vessels and muscles, but will also lead to an improvement in function and structure of the heart. Therefore, interval training will induce larger improvements in physical fitness and a larger improvement in prognosis for heart failure patients.

Study design:
Intervention study.

Study population;
84 heart failure patients.

Intervention:
Subjects will be randomly allocated to a 12-week intervention: 1. moderate-intensity exercise training, 2. high-intensity exercise training, or 3. control.

Main study parameters/endpoints:
1. Physical fitness (measured with a maximal cycling test);
2. NO-mediated endothelium-(in)dependent vasodilation of the forearm resistance arteries;
3. Contribution of ET to the baseline vascular tone of the forearm vascular bed.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:
The brachial catheterisation can induce a haematoma (~5%). However, this is completely reversible within 2 weeks and will not lead to permanent damage. Subjects will be informed regarding this potential risk associated with the invasive procedure of the test. During this test, also blood will be taken for later analysis. Therefore, the number of invasive procedures will be minimised to 2.
The pharmaceutical drugs are all accepted for human use and will be infused in the forearm only (not in systemic doses), leading to a localised effect only. In addition, all substances will be removed by the body within minutes to hours (dependent on the substance). Moreover, >4,000 studies have previously used one or more of these substances to examine the local effects of endothelin and nitric oxide in the arms or legs of healthy humans as well as various patient groups (including heart failure). To the best of our knowledge, none of these previous studies reported the presence of (serious) adverse events. Exercise training is not associated with a health risk. Moreover, exercise training typically causes a decreased cardiovascular risk, whilst vascular and cardiac function and structure improve after a period of exercise training. Also a number a previous studies have demonstrated that the cardiac workload during high intensity training is not significantly different to the (traditional)moderate-intensity training. Some studies have even demonstrated that the beneficial effects of exercise on remodelling of the heart are superior during high-intensity training compared with traditional moderate-intensity training in subjects with heart failure. Therefore, both types of exercise are not associated with an increased risk for development of health-related problems.
- Main changes (audit trail)
- RECORD22-okt-2012 - 10-nov-2012


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl